Islandski Lišaj Tad Pharma (Lichen Islandicus Extractum)

The precise pharmacology of Lichen Islandicus Extractum is not fully defined. Laboratory studies suggest the extract may provide antioxidant effects and modulate inflammatory pathways in mucosal tissues, which could underlie its traditional use for soothing irritation. Human data confirming these mechanisms are currently limited.

The dosage of Islandski Lišaj Tad Pharma is determined by the prescribing healthcare professional based on individual needs, formulation strength, and intended use. Patients should follow the specific instructions provided by their clinician and not alter the dose without medical guidance.

Safety data for Lichen Islandicus Extractum in pregnancy or lactation are insufficient. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using the product to weigh potential risks and benefits.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with other botanical respiratory aids, Islandski Lišaj Tad Pharma offers an oromucosal delivery of Lichen Islandicus Extractum, which is distinct from inhaled or oral capsule forms. While both aim to soothe throat irritation, differences in extraction methods, dosage forms, and regulatory status may affect efficacy and safety profiles.

The product should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keeping the container tightly sealed helps maintain stability and potency over its shelf life.

Islandski Lišaj Tad Pharma is administered via the oromucosal route. The prescribed amount is placed in the mouth and allowed to dissolve or be held briefly, ensuring contact with the oral mucosa before swallowing, as directed by a healthcare professional.

Serious risks, although rare, include allergic reactions such as rash, swelling, or difficulty breathing, and severe mucosal inflammation that may lead to ulceration. Immediate medical attention is required if any signs of anaphylaxis or persistent oral lesions develop.

Individuals with known hypersensitivity to lichens or related botanical extracts should avoid the product. It is also contraindicated in patients with active oral lesions, uncontrolled asthma, or those taking immunosuppressive or anticoagulant therapy without medical supervision.